At present, microsatellite instability (MSI), PD-L1, tumor mutation burden (TMB), DNA mismatch repair deficiency (dMMR) and TILs factors are the only factors that are confirmed to be able to predict the efficacy of ICI response (16, 17). The gene discussed is CD274; the disease is neoplasm.